Study backs Masimo hemoglobin monitoring during C-sections
Masimo (Nasdaq:MASI) today announced positive data from a study of its hemoglobin monitoring for patients undergoing cesarean section.
Source: massdevice.com
📰 Masimo Pulse News
Masimo Pulse News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Masimo Pulse. Real-time updates on events, politics, business and more.